These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33901923)

  • 1. Accuracy evaluation of the C. elegans cancer test (N-NOSE) using a new combined method.
    Inaba S; Shimozono N; Yabuki H; Enomoto M; Morishita M; Hirotsu T; di Luccio E
    Cancer Treat Res Commun; 2021; 27():100370. PubMed ID: 33901923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of an Early Cancer Detection Method Using the Olfaction of the Nematode Caenorhabditis elegans].
    Uozumi T; Hirotsu T
    Yakugaku Zasshi; 2019; 139(5):759-765. PubMed ID: 31061346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency of Gastrointestinal Cancer Detection by Nematode-NOSE (N-NOSE).
    Kusumoto H; Tashiro K; Shimaoka S; Tsukasa K; Baba Y; Furukawa S; Furukawa J; Niihara T; Hirotsu T; Uozumi T
    In Vivo; 2020; 34(1):73-80. PubMed ID: 31882465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A highly accurate inclusive cancer screening test using Caenorhabditis elegans scent detection.
    Hirotsu T; Sonoda H; Uozumi T; Shinden Y; Mimori K; Maehara Y; Ueda N; Hamakawa M
    PLoS One; 2015; 10(3):e0118699. PubMed ID: 25760772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new detection method for canine and feline cancer using the olfactory system of nematodes.
    Sugimoto T; Okuda Y; Shima A; Sugiura N; Kondo N; Ishihara G; Hirotsu T; di Luccio E
    Biochem Biophys Rep; 2022 Dec; 32():101332. PubMed ID: 36111250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of a diagnostic score for colon cancer based on serum CEA, CA19-9, cytokeratin-1 and mucin-1.
    Attallah AM; El-Far M; Ibrahim AR; El-Desouky MA; Omran MM; Elbendary MS; Attallah KA; Qura ER; Abdallah SO
    Br J Biomed Sci; 2018 Jul; 75(3):122-127. PubMed ID: 29734875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer.
    He CZ; Zhang KH; Li Q; Liu XH; Hong Y; Lv NH
    BMC Gastroenterol; 2013 May; 13():87. PubMed ID: 23672279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of Combined Detection of Serum CEA, CA72-4, CA19-9, CA15-3 and CA12-5 in the Diagnosis of Gastric Cancer.
    Chen C; Chen Q; Zhao Q; Liu M; Guo J
    Ann Clin Lab Sci; 2017 May; 47(3):260-263. PubMed ID: 28667025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
    Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
    Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
    Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
    Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses.
    Park BJ; Cha MK; Kim IH
    BMC Res Notes; 2014 Jan; 7():7. PubMed ID: 24393391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early Diagnosis of Cancer Using Nematoda C. elegans].
    Mizuguchi R; Hirotsu T
    Gan To Kagaku Ryoho; 2018 Jun; 45(6):916-920. PubMed ID: 30026413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer.
    Yin LK; Sun XQ; Mou DZ
    Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
    Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
    Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N(1),N(12)-Diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers.
    Hiramatsu K; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H; Tanaka S; Tanaka C; Tamamori Y; Imajo M; Kawaguchi M; Toi M; Mori T; Kawakita M
    Clin Cancer Res; 2005 Apr; 11(8):2986-90. PubMed ID: 15837752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.
    Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
    Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Clinical Significance of sICAM-1 in Differentiating Benign Breast Lesions from Breast Cancer.
    Chen C; Chen Q; Dong Y; Liu X
    Ann Clin Lab Sci; 2020 Sep; 50(5):650-656. PubMed ID: 33067211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
    Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
    Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.
    Bozkurt M; Yumru AE; Aral I
    Eur J Gynaecol Oncol; 2013; 34(6):540-4. PubMed ID: 24601047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural Response Alteration in
    Kusumoto H; Tashiro K; Shimaoka S; Tsukasa K; Baba Y; Furukawa S; Furukawa J; Suenaga T; Kitazono M; Tanaka S; Niihara T; Hirotsu T; Uozumi T
    Biomark Cancer; 2019; 11():1179299X19896551. PubMed ID: 31903024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.